Document is current
Any future updates will be listed below
-
Authors
Gomez-Ospina, Natalia
Potter, Carol J.
Xiao, Rui
Manickam, Kandamurugu
Kim, Mi-Sun
Kim, Kang Ho
Shneider, Benjamin L.
Picarsic, Jennifer L.
Jacobson, Theodora A.
Zhang, Jing
He, Weimin
Liu, Pengfei
Knisely, A. S.
Finegold, Milton J.
Muzny, Donna M.
Boerwinkle, Eric
Lupski, James R.
Plon, Sharon E.
Gibbs, Richard A.
Eng, Christine M.
Yang, Yaping
Washington, Gabriel C.
Porteus, Matthew H.
Berquist, William E.
Kambham, Neeraja
Singh, Ravinder J.
Xia, Fan
Enns, Gregory M.
Moore, David D.
- License Information
-
More Information
Article History
Received: 7 July 2015
Accepted: 11 January 2016
First Online: 18 February 2016
Competing interests
: B.L.S. is a consultant to Bristol Myers Squibb and Vertex Pharmaceuticals and has received investigator initiated support from Hyperion Therapeutics in the form of drug only for treatment of Byler’s Disease. All other authors declare no competing financial interests.
